Dillon Gee Status: Mets Pitcher Will Need Surgery, According To Report

New York Mets pitcher Dillon Gee could now be shut down for the season as he will need surgery on Friday to repair damage to a shoulder artery (via New York Daily News). Gee was hospitalized on Monday for a blood clot in his pitching shoulder which was causing finger numbness. He was placed on the 15-day disabled list on Tuesday. Doctors used a catheter to break up the clot.

Gee's surgery will be performed by Dr. Robert Thompson at Barnes-Jewish Hospital in St. Louis. While the young right-hander could resume throwing in six to eight weeks, his return before the end of the season does not appear likely.

In 17 starts, Gee is 6-7 this season with a 4.10 ERA.

Check back to this SB Nation New York StoryStream for more news on New York Mets' pitcher Dillon Gee. For more discussion of this topic, check out the SB Nation blog Amazin Avenue.

Trending Discussions

X
Log In Sign Up

forgot?
Log In Sign Up

Forgot password?

We'll email you a reset link.

If you signed up using a 3rd party account like Facebook or Twitter, please login with it instead.

Forgot password?

Try another email?

Almost done,

By becoming a registered user, you are also agreeing to our Terms and confirming that you have read our Privacy Policy.

Join SB Nation New York

You must be a member of SB Nation New York to participate.

We have our own Community Guidelines at SB Nation New York. You should read them.

Join SB Nation New York

You must be a member of SB Nation New York to participate.

We have our own Community Guidelines at SB Nation New York. You should read them.

Spinner.vc97ec6e

Authenticating

Great!

Choose an available username to complete sign up.

In order to provide our users with a better overall experience, we ask for more information from Facebook when using it to login so that we can learn more about our audience and provide you with the best possible experience. We do not store specific user data and the sharing of it is not required to login with Facebook.